Editorial Board

Editor-in-Chief

  • Ludvig Muren, MSc, PhD, Aarhus University Danish Centre for Particle Therapy, Aarhus N, Denmark, Proton therapy,   image-guided and adaptive therapy,   dose response modelling,   3D dosimetry
  • Daniela Thorwarth, MSc, PhD, Department of Radiation Oncology, Section for Biomedical Physics, Eberhard Karls University Tübingen, Tübingen, Germany, Medical Physics,  Radiotherapy,  functional imaging for radiation oncology,  image-guided radiotherapy

Editorial Board Members

  • Jan Bussink, MD, PhD, Radboudumc, Nijmegen, Netherlands, Lung cancer,  Radiobiology,  Hypoxia
  • Catharine Clark, PhD, MSc, Royal Surrey County Hospital, Department of Medical Physics, Guildford, Surrey, United Kingdom, Radiotherapy dosimetry,  advanced techniques,  clinical implementation
  • Luca Cozzi, MSc, PhD, Humanitas University, Milano, Italy, Radiotherapy Physics,  Treatment Planning,  Algorithms
  • Wouter van Elmpt, MSc, PhD, Maastricht University Medical Centre+, Maastricht, Netherlands, Radiotherapy Physics
  • Claudio Fiorino, PhD, Vita-Salute San Raffaele University, Milano, Italy, NTCP and TCP modelling,  adaptive radiotherapy,  planning optimization,  Radiomics,  clinical Radiobiology
  • Peter Greer, PhD, The University of Newcastle, Callaghan, Australia, Treatment verification,  EPID dosimetry,  MRI in radiotherapy,  MRI-only RT
  • Coen Hurkmans
  • Tomas Kron, PhD, Peter MacCallum Cancer Centre, Melbourne, Australia, Thermoluminescence dosimetry and its applications in medicine,  ionisation chambers,  radiotherapy physics,  clinical dosimetry
  • Pietro Mancosu, MSc, PhD, IRCCS Humanitas Research Hospital, Rozzano, Italy, External Beam Radiotherapy, Stereotactic Body Radiotherapy, Risk Management and Quality management, Automation in radiotherapy
  • Vitali Moiseenko, PhD, FAAPM, University of California San Diego, La Jolla, United States of America, External Beam Radiotherapy,  Stereotactic Body Radiotherapy,  Outcomes Data Analysis
  • Jasper Nijkamp, PhD, Aarhus University, Department of Clinical Medicine, Aarhus, Denmark, Image-guided radiotherapy, deep-learning based tumor segmentation, tumor imaging, correlative pathology, imaging validation
  • Sara Margareta Cecilia Pilskog, PhD, Haukeland University Hospital, Bergen, Norway, Adaptive radiotherapy, Organ motion modelling, Dose response, Hypoxia, Radiobiology
  • Kathrine Redalen, MSc, PhD, Norwegian University of Science and Technology, Trondheim, Norway, Magnetic resonance imaging (MRI),  Positron emission tomography (PET),  Quantitative imaging,  Machine learning,  Image-guided radiotherapy
  • Christian Richter, PhD, OncoRay - Nationales Zentrum fur Strahlenforschung in der Onkologie, Dresden, Germany, High precision radiotherapy,  translational research,  proton therapy,  dual-energy CT,  proton range verification
  • Núria Sala, MSc, PhD, Hospital of the Holy Cross and Saint Paul, Barcelona, Spain, Dosimetry,  Qualtiy Management,  Treatment planning,  Dose calculation algorithms,  Audits
  • Jan-Jakob Sonke, PhD, Antoni van Leeuwenhoek Netherlands Cancer Institute, Amsterdam, Netherlands, Image Guided Radiotherapy,  Adaptive Radiotherapy,  Outcome Modelling,  Image Analysis
  • Jamema Swamidas, PhD, Advanced Centre for Treatment Research and Education in Cancer, Navi Mumbai, India, Brachytherapy,  Deformable Image Registration,  Treatment Planning,  Quality Assurance
  • Neelam Tyagi, PhD, Memorial Sloan Kettering Cancer Center, New York, United States of America, MR-RT, MR-Linac, MR-guided radiation therapy, functional MRI
  • Uulke Van der Heide, PhD, The Netherlands Cancer Institute, Department of Radiotherapy, Amsterdam, Netherlands, Functional MRI,  MR-linac 
  • Dirk Verellen, PhD, University of Antwerp, Antwerpen, Belgium, Cancer Therapy,  Dosimetry,  Radiation Oncology,  Radiation Dosimetry,  Cancer Biology

Editorial Office

  • Paul Crabtree, Stover Court, Exeter, United Kingdom